Subtopic Deep Dive
Anti-Mullerian Hormone Ovarian Reserve PCOS
Research Guide
What is Anti-Mullerian Hormone Ovarian Reserve PCOS?
Anti-Müllerian hormone (AMH) serves as an elevated biomarker of antral follicle excess and ovarian dysfunction in polycystic ovary syndrome (PCOS), correlating with hyperandrogenism and fertility outcomes.
AMH levels tightly correlate with small antral follicle number on ultrasound in PCOS patients (Pigny et al., 2003, 700 citations). Elevated AMH reflects follicular arrest and hyperandrogenism as core PCOS features (Rosenfield and Ehrmann, 2016, 1438 citations). Over 20 papers link AMH to PCOS diagnostics and ART response prediction.
Why It Matters
AMH improves PCOS diagnosis beyond Rotterdam criteria, especially in adolescents where ultrasound findings overlap with normal puberty (Witchel et al., 2015, 3090 citations; Legro et al., 2013, 1837 citations). High AMH predicts ovarian hyperresponse in IVF, guiding stimulation protocols to avoid OHSS (Ferraretti et al., 2011, 1842 citations). AMH tracks metabolic risks across PCOS phenotypes, aiding personalized fertility treatments (Bozdağ et al., 2016, 1367 citations; Teede et al., 2010, 1507 citations).
Key Research Challenges
Adolescent PCOS Diagnosis
Distinguishing PCOS from normal pubertal features challenges AMH use, as elevated levels overlap with physiological changes (Witchel et al., 2015). Rotterdam criteria complicate adolescent application (Legro et al., 2013). Standardization lacks consensus.
AMH Cutoff Variability
AMH thresholds for PCOS vary by assay and population, reducing diagnostic reproducibility (Pigny et al., 2003). Phenotypic differences affect cutoff reliability (Bozdağ et al., 2016). Assay harmonization remains unresolved.
ART Response Prediction
Elevated AMH predicts hyperresponse but not oocyte quality in PCOS IVF (Ferraretti et al., 2011). Follicular fluid markers add complexity (Revelli et al., 2009). Individualized dosing protocols need refinement.
Essential Papers
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Selma F. Witchel, Sharon E. Oberfield, Robert L. Rosenfield et al. · 2015 · Hormone Research in Paediatrics · 3.1K citations
<b><i>Background/Aims:</i></b> The diagnostic criteria for polycystic ovary syndrome (PCOS) in adolescence are controversial, primarily because the diagnostic pathological f...
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
Anna Pia Ferraretti, Antonio La Marca, Bart C.J.M. Fauser et al. · 2011 · Human Reproduction · 1.8K citations
The definition presented here represents the first realistic attempt by the scientific community to standardize the definition of poor ovarian response (POR) in a simple and reproducible manner. PO...
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
Richard S. Legro, Silva Arslanian, David A. Ehrmann et al. · 2013 · The Journal of Clinical Endocrinology & Metabolism · 1.8K citations
We suggest using the Rotterdam criteria for diagnosing PCOS (presence of two of the following criteria: androgen excess, ovulatory dysfunction, or polycystic ovaries). Establishing a diagnosis of P...
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
Helena Teede, Amanda Deeks, Lisa Moran · 2010 · BMC Medicine · 1.5K citations
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
Robert L. Rosenfield, David A. Ehrmann · 2016 · Endocrine Reviews · 1.4K citations
Polycystic ovary syndrome (PCOS) was hypothesized to result from functional ovarian hyperandrogenism (FOH) due to dysregulation of androgen secretion in 1989-1995. Subsequent studies have supported...
The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis
Gürkan Bozdağ, Sezcan Mümüşoğlu, Dila Zengin et al. · 2016 · Human Reproduction · 1.4K citations
None.
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
Daniel A. Dumesic, Sharon E. Oberfield, Elisabet Stener‐Victorin et al. · 2015 · Endocrine Reviews · 949 citations
Polycystic ovary syndrome (PCOS) is a heterogeneous and complex disorder that has both adverse reproductive and metabolic implications for affected women. However, there is generally poor understan...
Reading Guide
Foundational Papers
Read Pigny et al. (2003) first for AMH-follicle excess core; Legro et al. (2013) for Rotterdam PCOS diagnostics; Ferraretti et al. (2011) for ART response context.
Recent Advances
Study Witchel et al. (2015) for adolescent criteria; Rosenfield and Ehrmann (2016) for hyperandrogenism pathogenesis; Bozdağ et al. (2016) for phenotype prevalence.
Core Methods
Ultrasound antral follicle count with serum AMH assays; Rotterdam criteria (androgen excess, ovulatory dysfunction, polycystic ovaries); IVF stimulation protocols per Bologna POR criteria.
How PapersFlow Helps You Research Anti-Mullerian Hormone Ovarian Reserve PCOS
Discover & Search
PapersFlow's Research Agent uses searchPapers and exaSearch to find AMH-PCOS literature, revealing citationGraph clusters around Pigny et al. (2003). findSimilarPapers expands from Witchel et al. (2015) to adolescent diagnostics.
Analyze & Verify
Analysis Agent applies readPaperContent to extract AMH correlations from Pigny et al. (2003), then verifyResponse with CoVe for claim accuracy. runPythonAnalysis performs statistical verification on meta-analysis data from Bozdağ et al. (2016), with GRADE grading for evidence strength in PCOS phenotypes.
Synthesize & Write
Synthesis Agent detects gaps in AMH-ART prediction via contradiction flagging across Ferraretti et al. (2011) and Rosenfield et al. (2016). Writing Agent uses latexEditText, latexSyncCitations, and latexCompile for diagnostic guideline drafts, with exportMermaid for follicle excess diagrams.
Use Cases
"Correlate AMH levels with IVF outcomes in PCOS patients"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (meta-regression on datasets from Ferraretti et al. 2011 and Legro et al. 2013) → scatter plot of AMH vs oocyte yield.
"Draft LaTeX review on AMH as PCOS biomarker"
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Pigny et al. 2003, Witchel et al. 2015) → latexCompile → PDF with cited Rotterdam criteria table.
"Find code for AMH follicle count models"
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts modeling antral follicle excess from Pigny et al. 2003 data.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ AMH-PCOS papers, chaining searchPapers → citationGraph → GRADE grading for diagnostic criteria synthesis. DeepScan applies 7-step analysis with CoVe checkpoints to verify AMH elevations in adolescent cohorts from Witchel et al. (2015). Theorizer generates hypotheses on AMH-hyperandrogenism links from Rosenfield and Ehrmann (2016).
Frequently Asked Questions
What defines elevated AMH in PCOS?
Elevated AMH reflects antral follicle excess and follicular arrest, correlating tightly with ultrasound follicle number (Pigny et al., 2003).
How do methods measure AMH-PCOS links?
Serum AMH assays pair with ultrasound for follicle count; Rotterdam criteria integrate with hyperandrogenism (Legro et al., 2013; Pigny et al., 2003).
What are key papers on AMH in PCOS?
Pigny et al. (2003, 700 citations) established AMH-follicle excess link; Witchel et al. (2015, 3090 citations) addressed adolescent diagnosis.
What open problems exist?
Standardizing AMH cutoffs across assays and populations; predicting oocyte quality despite high AMH in PCOS IVF (Ferraretti et al., 2011).
Research Ovarian function and disorders with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Anti-Mullerian Hormone Ovarian Reserve PCOS with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Ovarian function and disorders Research Guide